Valeritas, which makes the V-Go insulin delivery device, registers for an initial public offering worth $90 million at the midpoint.
Valeritas yesterday registered for an initial public offering worth up to $90 million for its V-Go insulin delivery system.
Bridgewater, N.J.-based Valeritas said it plans to list on the NASDAQ exchange under the "VLRX" symbol.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1DoCnoK
Cap comentari:
Publica un comentari a l'entrada